Male patients with clinical BPH , elevated serum PSA ( > @ng/ml ) , and significant LUTS ( International Prostate Symptom Score -LSB- IPSS -RSB- @ ) were randomly assigned to receive doxazosin @mg daily plus celecoxib @mg daily ( study group ) or doxazosin @mg daily alone ( control group ) for @months .